FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.

Autres langues Fujian Cosunter Pharmaceutical Co., Ltd.

Actions

300436

CNE100001YZ0

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 06/05/2024			Varia. 5j.	Varia. 1 janv.
18,71 ^CNY	+4,29%		+6,61%	-27,00%

19/04	Fujian Cosunter Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
2023	Fujian Cosunter Pharmaceutical Co. publie ses résultats pour les neuf mois se terminant le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Jiangsu Zhongxing Pharm Co., Ltd. cancelled the transaction announced on July 5, 2021	29/12
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Fujian Cosunter Pharmaceutical Co., Ltd.(XSEC:300436) added to S&P Global BMI Index	18/09/23
Fujian Cosunter Pharmaceutical Co., Ltd. agreed to acquire remaining 5.8333% stake in Jiangsu Zhongxing Pharm Co., Ltd. from Zhang Zhijun for CNY 10.6 million.	12/09/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Cosunter Pharma Signs 14 Million Yuan Equipment Purchase Deal	27/06/23
Fujian Cosunter Pharma's Unit Completes Clinical Trials on COVID-19 Drug	21/06/23
Fujian Cosunter Pharma Gets Nod to Market Men's Drug	19/06/23
Fujian Cosunter Pharma Completes Enrollment for COVID-19 Drug; Shares Drop 3%	05/05/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Fujian Cosunter Pharma Unit Gets Drug Production License from Provincial Regulator	15/03/23
Chinese Shares End Mixed; Cosunter Pharma Rallies 11% as COVID-19 Drug Seen More Effective Versus Pfizer's	10/01/23
Fujian Cosunter Pharma Says COVID-19 Drug More Effective Than Pfizer’s Paxlovid; Shares Rally 14%	10/01/23
Fujian Cosunter Pharma Selling 948 Million Yuan Shares to Fund New Drug Research Platform	09/01/23
Fujian Cosunter Pharmaceutical Co., Ltd. announced that it expects to receive CNY 948 million in funding	05/01/23
Fujian Cosunter Pharma Enrolls First Patient for Anti-COVID Drug Trial	22/12/22
Fujian Cosunter’s Trial of Anti-COVID Tablets Shows Drug’s Safety; Shares Up 4%	12/12/22
Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Fujian Cosunter Pharmaceutical Co., Ltd.

Actions

300436

CNE100001YZ0

Autres langues

Filtres